Share this article:
Irvine-based startup device maker JenaValve Technology Inc. said today it completed a $26.5 million found of financing.
JenaValve develops, manufactures and markets transcatheter aortic heart valves and delivery systems.
The company said in a statement that it would use proceeds to support its further growth in that product market.
Great Britain’s Valiance Asset Management Ltd., along with Belgian-based RMM, co-led the financing round. Existing JenaValve investors also participated, including Edmond de Rothschild Investment Partners.
JenaValve’s devices have European approval and are sold in select overseas markets. The company is private and does not disclose financial results.